Aging Mastery Program® (AMP) Evaluation (AMP)

December 6, 2019 updated by: Catherine A. Sarkisian, University of California, Los Angeles

Evaluation of Aging Mastery Program® in Senior Centers Throughout Los Angeles County

The Aging Mastery Program® (AMP) is designed to inform, encourage, and support older adults as they take steps to improve their lives and stay engaged in their communities. The program incorporates evidence-informed materials, expert speakers, group discussion, peer support, and small rewards to give participants the skills and tools they need to achieve measurable improvements in managing their health, remaining economically secure, and contributing actively to society. L.A. CAPRA in partnership with the National Council on Aging, City of Los Angeles and the Los Angeles County Department of Aging will evaluate the effectiveness of the AMP program across 5 community-based senior sites. The overall objective of the proposed study is to evaluate the effectiveness of AMP program on improving the health and well-being of older adults using a randomized wait-list controlled trial.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Aging Mastery Program® (AMP) offers community-based organizations a clear path to engage older adults and address the physical, financial, and emotional wellness of older adults. First piloted nationally in five senior centers, AMP incorporates evidence-based materials, expert speakers, group discussion, and peer support to give participants the skills and tools they need to achieve measurable improvements in managing their health and remaining economically secure. The program aims to empower seniors to make and maintain small, impactful changes to their behaviors to live a healthier, happier, and more secure life. AMP has been field-tested in various rural and urban setting, senior centers, and across an ethnically diverse middle-aged and older adult population, reaching almost 6,000 since 2013. Currently, the program is being evaluated through a quasi-experimental study in New York State and under consideration as an evidence-based program.

The National Council on Aging study team will train six program leads from the City of Los Angeles Department of Aging and Los Angeles Area on Aging to implement Aging Mastery Program® (AMP). The intervention will consist of a 10-week series held once-a-week for an hour and half (90 minutes). It will be group-based and led by trained facilitators and designated expert speakers in a community-based setting (senior centers). The program reviews 10 central areas of aging (1) navigating longer lives, (2) physical activity, (3) sleep, (4) healthy eating and hydration, (5) financial security, (6) medication management, (7) advance care planning, (8) healthy relationships, (9) falls prevention, and (10) community engagement. The intervention is based in social cognitive theory and attribution retraining and incorporates elements such as verbal persuasion, goal setting, problem solving, and attribution retraining techniques that encourage students to adopt controllable and unstable explanations.

Study Participants (N=200 or n=40/site) will be recruited from 5 study sites to participate in the Aging Mastery Program. UCLA study personnel will be on-site to consent older adults to participate in the evaluation of intervention and take part of baseline and post-intervention assessments. Upon signing the consent, study staff will collect self-administered baseline data (measures and measurement tools --i.e. Patient Information Survey, PROMIS and Patient Activation Survey (PAM) from all participants (n=200). After baseline data has been collected, participants will be randomized and assigned to either the immediate intervention groups (n=100 intervention) or the wait-list control (n=100). At each site, forty participants will be in the intervention group and 40 will be in wait-list control. Following the 10-week Aging Mastery Program®, post-intervention assessment (measures and measurement tools --i.e. Patient Information Survey, Patient Satisfaction, PROMIS and PAM) will be administered. During the data collection sessions, study staff will go to community sites and collect post-treatment self-reported assessment

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Lancaster, California, United States, 93534
        • Antelope Valley Senior Center
      • Los Angeles, California, United States, 90036
        • Freda Mohr Multipurpose Center
      • Montebello, California, United States, 90012
        • Potrero Heights Community Center
      • San Pedro, California, United States, 90012
        • San Pedro Service Center
      • Sherman Oaks, California, United States, 91403
        • Sherman Oaks East Valley Adult Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Available to attend the baseline and post-treatment data collection session and subsequent weekly intervention sessions
  2. Available to speak and understand English
  3. Plans to be living in the region during the next 6 months
  4. Has cognitive ability to provide informed consent to participate

Exclusion Criteria:

  1. Cannot Speak or Communicate well in English
  2. Unavailable to attend the baseline data collection session and subsequent weekly intervention sessions
  3. Plans to move away from the region during the next 6 months
  4. Lacks cognitive ability to provide informed consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Immediate exposure to the 10-week Aging Mastery Program (AMP)
Behavioral: Intervention
Participants receive the AMP 10-week program immediately
Placebo Comparator: Wait-list Group
Class to start 3 months after the Intervention Group
Behavioral: Control
Participants will not received the AMP 10-week program immediately, rather will wait 3-months
Other Names:
  • Waitlist Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvements in health and well-being
Time Frame: Pre-intervention (baseline) and questions will be repeated again 10-weeks after the baseline (for waitlist control/for those in class immediately after the class) as a Post-intervention.
Patient self-reported questionnaire PROMIS scale; SF-16
Pre-intervention (baseline) and questions will be repeated again 10-weeks after the baseline (for waitlist control/for those in class immediately after the class) as a Post-intervention.
Improvements in Patient Activation
Time Frame: Pre-intervention (baseline) and questions will be repeated again 10-weeks after the baseline (for waitlist control/for those in class immediately after the class) as a Post-intervention.
Patient self-reported questionnaire PAM scale
Pre-intervention (baseline) and questions will be repeated again 10-weeks after the baseline (for waitlist control/for those in class immediately after the class) as a Post-intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of California, Los Angeles

Collaborators

The National Council on Aging
City of Los Angeles Department of Aging
Los Angeles County Area Agency on Aging

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

March 15, 2018

Study Completion (Actual)

March 15, 2018

Study Registration Dates

First Submitted

October 12, 2017

First Submitted That Met QC Criteria

November 13, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

December 10, 2019

Last Update Submitted That Met QC Criteria

December 6, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • IRB #17-000137

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe